全文获取类型
收费全文 | 84330篇 |
免费 | 7520篇 |
国内免费 | 3799篇 |
专业分类
耳鼻咽喉 | 840篇 |
儿科学 | 982篇 |
妇产科学 | 1291篇 |
基础医学 | 11439篇 |
口腔科学 | 1887篇 |
临床医学 | 8675篇 |
内科学 | 14520篇 |
皮肤病学 | 1313篇 |
神经病学 | 5342篇 |
特种医学 | 2834篇 |
外国民族医学 | 21篇 |
外科学 | 10205篇 |
综合类 | 10345篇 |
现状与发展 | 14篇 |
一般理论 | 5篇 |
预防医学 | 5373篇 |
眼科学 | 2290篇 |
药学 | 8381篇 |
51篇 | |
中国医学 | 2994篇 |
肿瘤学 | 6847篇 |
出版年
2024年 | 108篇 |
2023年 | 733篇 |
2022年 | 1844篇 |
2021年 | 2623篇 |
2020年 | 1815篇 |
2019年 | 1797篇 |
2018年 | 2409篇 |
2017年 | 2023篇 |
2016年 | 1902篇 |
2015年 | 2623篇 |
2014年 | 3316篇 |
2013年 | 3420篇 |
2012年 | 4854篇 |
2011年 | 4813篇 |
2010年 | 3160篇 |
2009年 | 2795篇 |
2008年 | 3505篇 |
2007年 | 3550篇 |
2006年 | 3361篇 |
2005年 | 2727篇 |
2004年 | 2382篇 |
2003年 | 2466篇 |
2002年 | 2123篇 |
2001年 | 5350篇 |
2000年 | 5081篇 |
1999年 | 4429篇 |
1998年 | 1640篇 |
1997年 | 1315篇 |
1996年 | 846篇 |
1995年 | 704篇 |
1994年 | 619篇 |
1993年 | 503篇 |
1992年 | 2038篇 |
1991年 | 1778篇 |
1990年 | 1604篇 |
1989年 | 1550篇 |
1988年 | 1362篇 |
1987年 | 1237篇 |
1986年 | 1103篇 |
1985年 | 922篇 |
1984年 | 597篇 |
1983年 | 474篇 |
1982年 | 252篇 |
1981年 | 183篇 |
1980年 | 144篇 |
1979年 | 282篇 |
1978年 | 77篇 |
1974年 | 75篇 |
1973年 | 95篇 |
1972年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 克隆土耳其斯坦东毕吸虫磷酸丙糖异构酶的全长基因。方法 根据日本血吸虫和曼氏血吸虫磷酸丙糖异构酶基因的保守区设计引物,利用RT—PCR扩增出土耳其斯坦东毕吸虫磷酸丙糖异构酶基闪的大片段,再结合RACE技术分别得到磷酸丙糖异构酶基因的3’端和5’端,将3部分序列拼接后获得磷酸丙糖异构酶基因全长cDNA序列,并提交GenBank。结果 成功克隆了土耳其斯坦东毕吸虫磷酸丙糖异构酶基因全长cDNA序列并提交GenBank,登录号为DQ092331。结论 土耳其斯坦东毕吸虫磷酸丙糖异构酶基因全长cDNA的克隆为进一步表达及其生物学性能的分析提供了理论基础。 相似文献
3.
4.
J Phua E S C Koay D Zhang L K Tai X L Boo K C Lim T K Lim 《The European respiratory journal》2006,28(4):695-702
Levels of the soluble form of the triggering receptor expressed on myeloid cells (sTREM)-1 are elevated in severe sepsis. However, it is not known whether sTREM-1 measurements can distinguish milder bacterial infections from noninfectious inflammation. The present authors studied whether serum sTREM-1 levels differ in community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD), asthma and controls, and whether sTREM-1 may be used as a surrogate marker for the need for antibiotics. Serum sTREM-1 levels in 150 patients with pneumonia, COPD and asthma exacerbations and 62 healthy controls were measured. Serum sTREM-1 levels were significantly elevated in pneumonia (median 295.2 ng x mL(-1)), COPD (280.3 ng x mL(-1)) and asthma exacerbations (184.0 ng x mL(-1)) compared with controls (83.1 ng x mL(-1)). Levels were higher in pneumonia and Anthonisen type 1 COPD exacerbations than in type 2 and 3 COPD and asthma exacerbations. The area under the receiver operating characteristics curve for sTREM-1 as a surrogate marker for the need for antibiotics was 0.77. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 were elevated predominantly in pneumonia and Anthonisen type 1 COPD exacerbations versus type 2 and 3 chronic obstructive pulmonary disease exacerbations, asthma and controls. Serum levels of the soluble form of the triggering receptor expressed on myeloid cells-1 has moderate but insufficient accuracy as a surrogate marker for the need for antibiotics in lower respiratory tract infections. 相似文献
5.
6.
A. HAZIOT I. KATZ G. W. RONG X. Y. LIN J. SILVER & S. M. GOYERT 《Scandinavian journal of immunology》1997,46(3):242-245
Membrane-bound CD14 acts as a receptor for lipopolysaccharide (LPS) on monocytes/macrophages and neutrophils. Studies have suggested that the activation of monocytes/macrophages by the binding of LPS to membrane-bound CD14 may require the association of a signal-transducing molecule with membrane-bound CD14. The observation that non-CD14 expressing cells, such as endothelial cells, can nevertheless be activated by a complex of LPS and a soluble form of CD14 (sCD14) suggests that the receptor for this complex may be identical to the signal transducing molecule associated with membrane-bound CD14. The studies described show that two CD14-specific MoAb are able to block the LPS-induced activation of endothelial cells but do not affect the response of monocytes to LPS. This suggests that the interaction of the sCD14:LPS complex with endothelial cells is distinct from the interaction of membrane-bound CD14 with its putative signal-transducing molecule. 相似文献
7.
V. S. Akhunov T. V. Mirenburg X. D. Krasnopolskaya 《Journal of inherited metabolic disease》1994,17(1):104-111
Summary GM1- and GM2-gangliosides were isolated from brain and radio-labelled. The labelled moieties were localized by hydrolysis with lysosomal enzymes, followed by thin-layer chromatography of the products. High-resolution loading tests with labelled gangliosides were developed and found to differentiate infantile and juvenile forms of GM1- and GM2-gangliosidoses as well as the identification of B, O and AB types of GM2-gangliosidosis. 相似文献
8.
医源性胆管狭窄X线表现 总被引:1,自引:0,他引:1
本文报道了13例医源性胆管狭窄,分析其影像表现。特点为:环形狭窄;线样狭窄,包括规则的和不规则的线样狭窄;闭塞性狭窄;胆管闭塞和胆管中断分离。ERCT和PCT对狭窄的形态,位置及长度显示优于CT和US。 相似文献
9.
Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets 总被引:8,自引:0,他引:8
Prolonged survival of pancreatic islet allografts implanted in diabetic BB rats was achieved by encapsulation of individual islets in a protective biocompatible alginate-polylysine-alginate membrane without immunosuppression. Intraperitoneal transplantation of the encapsulated islets reversed the diabetic state of the recipients within 3 days and maintained normoglycemia for 190 days. Normal body weight and urine volume were maintained during this period, and no cataracts were detected in the transplant recipients. In contrast, control rats receiving transplants of unencapsulated islets experienced normoglycemia for less than 2 wk. These results demonstrated that microencapsulation can protect allografted islets from both graft rejection and autoimmune destruction without immunosuppression in an animal model that mimics human insulin-dependent diabetes. 相似文献
10.
Two unique forms of cytochrome P-450 (P-450), designated NMa and NMb, were recently isolated in this laboratory from nasal microsomes of rabbits. In the present study, polyclonal antibodies to the purified nasal cytochromes were prepared. Immunochemical analysis with specific rabbit anti-NMa and sheep anti-NMb antibodies indicated that P-450 isozymes identical to or having a high structural homology with NMa are present in both olfactory and respiratory mucosa, as well as in liver, but NMb was detected only in the olfactory mucosa. Neither form was detected in other tissues examined, including brain, esophageal mucosa, heart, intestinal mucosa, kidney, and lung. The specific occurrence of NMb in the olfactory mucosa was further substantiated by the detection and specific inhibition by anti-NMb of the formation of unique NMb-dependent metabolites of testosterone in olfactory microsomes but not in microsomes from liver or respiratory mucosa. Similar experiments with antibodies to previously purified rabbit hepatic P-450 isozymes indicated that not all of the hepatic cytochromes are expressed in the nasal tissues. Thus, P-450 isozymes structurally homologous to hepatic forms 2, 3a, and 4, but not 3b and 6, were found in the olfactory mucosa. On the other hand, only form 2 was detected in the respiratory mucosa. Immunoquantitation experiments revealed that NMa and NMb are the major P-450 forms in olfactory microsomes, whereas NMa and P-450 form 2 (or its homolog) constitute the major portion of the respiratory nasal microsomal P-450. The level of NMa in the liver is relatively low, accounting for less than 3% of total microsomal P-450 in this tissue. In addition, evidence is provided that NMa is the major catalyst in the dealkylation of two nasal carcinogens, hexamethylphosphoramide and phenacetin, in both olfactory and respiratory nasal microsomes. 相似文献